Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Celadon Pharmaceuticals (CEL)

Price 20.50p on 05-02-2025 at 09:00:29
Change 0.00p 0%
Buy 23.00p
Sell 18.00p
Buy / Sell CEL Shares
Last Trade: Buy 8,181.00 at 22.50p
Day's Volume: 14,045
Last Close: 20.50p
Open: 20.50p
ISIN: GB00BDQYGP38
Day's Range 20.50p - 22.50p
52wk Range: 12.00p - 122.50p
Market Capitalisation: £14m
VWAP: 22.02684p
Shares in Issue: 69m

Recent Trades History Celadon Pharmaceuticals (CEL)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 8,181 22.50p Suspected BUY Trade
09:00:29 - 05-Feb-25
Buy* 274 23.00p SI Trade
08:32:07 - 05-Feb-25
Buy* 37 23.00p SI Trade
08:32:07 - 05-Feb-25
Buy* 9 23.00p SI Trade
08:32:07 - 05-Feb-25
Buy* 8 23.00p Ordinary
08:32:04 - 05-Feb-25
Buy* 89 23.00p SI Trade
08:14:38 - 05-Feb-25
Buy* 197 23.00p SI Trade
08:14:38 - 05-Feb-25
Buy* 187 23.00p SI Trade
08:14:38 - 05-Feb-25
Buy* 21 23.00p SI Trade
08:14:38 - 05-Feb-25
Buy* 43 23.00p SI Trade
08:14:38 - 05-Feb-25

Share Price History for Celadon Pharmaceuticals

Time period:
to
Date Open High Low Close Volume

Share News for Celadon Pharmaceuticals

LONDON MARKET MIDDAY: Stocks up but Pearson, Dunelm fail to impress

16th Jan 2025 11:44

(Alliance News) - Stock prices in London were higher at midday on Thursday, shrugging off the Office for National Statistics' report of "sluggish" GDP growth. Read More

AIM WINNERS & LOSERS: Deltex to cancel "onerous" AIM listing

16th Jan 2025 10:47

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

LONDON MARKET OPEN: FTSE 100 higher but Taylor Wimpey leads laggers

16th Jan 2025 09:01

(Alliance News) - Stock prices in London opened higher on Thursday, despite early data showing that UK GDP growth undershot expectations and that the UK's trade deficit widened. Read More

IN BRIEF: Celadon receives payment, has working capital to March

2nd Jan 2025 12:07

Celadon Pharmaceuticals PLC - London-based pharmaceutical company, focused on cannabis-based medicines - Says the provider of its committed credit facility has transferred an additional GBP147,000 under the GBP1.0 million draw down request. The company expects to receive the outstanding GBP103,000 during January. Celadon says receipt of these funds along with expected cash receipts from customers and continuing to work with creditors gives the company sufficient working capital up to March. Read More

TRADING UPDATES: SDX plots AIM exit; Celadon receives funds

6th Dec 2024 15:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,567.72
Change-3.05

Login to your account

Forgot Password?

Not Registered